← Leaderboards
Jennifer Ann Frontera
New York University School Of Medicine
$1,839,413
Attributed
$5,518,240
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$5,518,240 · 1
By mechanism
R01$5,518,240 · 1
Top collaborators
- Yulin Ge4 shared
- Thomas M Wisniewski4 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Yulin Ge$12,393,958
- Piotr Konieczny$214,920
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposCovid-19 SeverityCerebrumCovid-19 PandemicAge Related NeurodegenerationAmyloid Beta-ProteinAtrophicBiological MarkersBlood - Brain Barrier Anatomy2019-NcovCovid-19Brain FogBrain VolumeCerebrovascular CirculationAgedClinical Dementia Rating ScaleClinical TrialsCognitionCognitiveCognitive PerformanceCognitive TestingBlood-Brain Barrier DisruptionCovid-19 PatientData Set
Grant awards (4)
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,361,420
R01 · FY2025 · AG
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,389,203
R01 · FY2024 · AG
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,389,203
R01 · FY2023 · AG
Alzheimerâs Disease Related Biomarkers following SARS-CoV-2 Infection$1,378,414
R01 · FY2022 · AG